STAAR SURGICAL CO cotiza a 21.50 USD y tiene una capitalización bursátil de $1.1B. En los últimos 12 meses ha facturado $340M con un margen de flujo de caja libre del -16.7%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells phakic implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The company offers implantable collamer lens product family (ICLs) comprising EVO ICL, EVO+ ICL, EVO Visian ICL, and…
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-03 |
|---|---|---|---|---|
| Real | — | $0.25 | $0.29 | $0.01 |
| Estimado | $0.17 | $0.23 | $0.08 | $0.17 |
| Sorpresa | — | +8.7% | +262.5% | -94.1% |
| Métrica | STAA | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 76.2% | 57.0% | +19.1% |
| Operating Margin | -38.3% | -38.6% | +0.3% |
| Net Margin | -33.6% | -33.6% | -0.0% |
| FCF Margin | -16.7% | -13.9% | -2.9% |
| ROE | -23.4% | -40.4% | +17.0% |
| ROA | -17.8% | -32.0% | +14.2% |
| Current Ratio | 4.55 | 2.84 | +1.71 |
| Debt / Equity | — | 0.28 | — |